Draft Policy paper on traceability of medical products

October 2020

Draft Policy paper on traceability of medical products

Overview

This policy paper outlines the features of existing traceability systems and provides guidance on developing workable traceability regulation. In the light of the widely varying needs, capacity, and resources of Member States, the risk mitigation and sustainability strategies embedded in implementation efforts will vary. Given the range of possible implementation pathways, a set of guiding principles will assist Member States in establishing systems best suited to their needs and constraints.

Annexes only available in the English version

This is a draft intended for review by Member States and all interested parties for the purpose of consultation. The content of this document is not final, and the text may be subject to revisions before publication.
WHO Team
Incidents and SF (ISF)
Number of pages
26